What are the latest clinical trials for Liver Cancer in 2026

Latest Clinical Trials for Liver Cancer in 2026

I appreciate your question about current clinical trials. However, I need to be transparent with you: I don't have access to real-time clinical trial databases or information about trials launching specifically in 2026. My knowledge has a cutoff date, and clinical trials are constantly being updated, opened, and closed.

What I CAN Tell You Based on Current Guidelines

According to the NCCN Guidelines for Hepatocellular Carcinoma (Version 2.2025), here's what's important to know about clinical trials for liver cancer:

Key Recommendation:

"Patient participation in prospective clinical trials is encouraged for the treatment of patients with all stages of disease."

This means your care team should actively discuss clinical trial opportunities with you, regardless of your disease stage.

Treatment Approaches Currently Being Studied

Based on the latest NCCN guidelines, active research areas include:

Immunotherapy combinations:

• Checkpoint inhibitor combinations (like tremelimumab plus durvalumab, which showed 5-year survival data updates in 2025)
• Nivolumab-based approaches for advanced HCC

Targeted therapies:

• TRK fusion-positive cancers (larotrectinib, entrectinib, repotrectinib)
• Molecular profiling-guided treatments

Combination approaches:

• Atezolizumab plus bevacizumab (already FDA-approved, but ongoing studies)
• Neoadjuvant (pre-surgery) immunotherapy options

How to Find Current 2026 Trials

Best resources for finding active trials:

1. ClinicalTrials.gov (National Institutes of Health)

   • Search: "hepatocellular carcinoma" + your location
   • Filter by status: "Recruiting" or "Active, not recruiting"

2. Cancer.gov (National Cancer Institute)

   • NCI's Cancer Clinical Trials search
   • Includes trials at NCI-designated cancer centers

3. Your oncology team

   • They have access to trials matching YOUR specific situation
   • They know which trials are actively enrolling in your area

4. NCCN Member Institutions

   • Many major cancer centers have dedicated trial coordinators

Questions to Ask Your Oncologist About Trials

Since the NCCN emphasizes trial participation, here are specific questions:

1. "Are there any clinical trials available for my stage and type of liver cancer?"
2. "What are the eligibility requirements, and do I meet them?"
3. "How would a trial compare to standard treatment options for me?"
4. "What are the potential benefits and risks of trial participation?"
5. "Can you help me access ClinicalTrials.gov to review options?"

Important Context

According to NCCN Guidelines, multidisciplinary team evaluation is essential before starting any treatment. This means your care should involve:

• Hepatologists (liver specialists)
• Surgical oncologists
• Medical oncologists
• Interventional radiologists
• Potentially others

This team approach helps identify which trials might be most appropriate for your specific situation.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about clinical trial participation.